SE7504150L - Prostaglandin kompositioner - Google Patents
Prostaglandin kompositionerInfo
- Publication number
- SE7504150L SE7504150L SE7504150A SE7504150A SE7504150L SE 7504150 L SE7504150 L SE 7504150L SE 7504150 A SE7504150 A SE 7504150A SE 7504150 A SE7504150 A SE 7504150A SE 7504150 L SE7504150 L SE 7504150L
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- double bond
- pgf
- pge
- dihydro
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003180 prostaglandins Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 8
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 6
- 125000002723 alicyclic group Chemical group 0.000 abstract 2
- PSUXJJCBYWUFQC-KSNMPCKYSA-N (z)-7-[(1r,2r,3r)-3-hydroxy-2-[(3s)-3-hydroxyoctyl]-5-oxocyclopentyl]hept-5-enoic acid Chemical compound CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O PSUXJJCBYWUFQC-KSNMPCKYSA-N 0.000 abstract 1
- 101000692460 Bos taurus Prostaglandin F synthase 1 Proteins 0.000 abstract 1
- 101000692466 Bos taurus Prostaglandin F synthase 2 Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000004015 abortifacient agent Substances 0.000 abstract 1
- 231100000641 abortifacient agent Toxicity 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 230000002196 ecbolic effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 230000003169 placental effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB16242/74A GB1484591A (en) | 1974-04-11 | 1974-04-11 | Prostaglandin compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7504150L true SE7504150L (sv) | 1975-10-13 |
Family
ID=10073769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7504150A SE7504150L (sv) | 1974-04-11 | 1975-04-10 | Prostaglandin kompositioner |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3978229A (fr) |
| AU (1) | AU497401B2 (fr) |
| BE (1) | BE827804A (fr) |
| CA (1) | CA1049410A (fr) |
| DK (1) | DK137977B (fr) |
| FR (1) | FR2267091B1 (fr) |
| GB (1) | GB1484591A (fr) |
| IE (1) | IE40977B1 (fr) |
| LU (1) | LU72258A1 (fr) |
| NL (1) | NL7504303A (fr) |
| SE (1) | SE7504150L (fr) |
| ZA (1) | ZA752304B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4152524A (en) * | 1974-04-02 | 1979-05-01 | American Cyanamid Company | Cycloalkyl and cycloalkenyl prostaglandin congeners |
| GB1494321A (en) * | 1974-08-08 | 1977-12-07 | Ici Ltd | Prostanoic acid derivatives |
| DE2524955C3 (de) * | 1975-06-05 | 1981-12-03 | Hoechst Ag, 6000 Frankfurt | Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung |
| US4028396A (en) * | 1975-07-02 | 1977-06-07 | American Cyanamid Company | 16,16-Spirocycloalkyl prostaglandin derivatives |
| JPS5395958A (en) * | 1977-01-31 | 1978-08-22 | Ono Pharmaceut Co Ltd | Prostaglandin analogues and process for their preparation |
| US4123463A (en) * | 1978-03-21 | 1978-10-31 | The Upjohn Company | 2-Decarboxy-2-alkylketone prostaglandins |
| US4289785A (en) * | 1980-08-06 | 1981-09-15 | The Upjohn Company | Method and compositions involving prostaglandins |
| GB8324004D0 (en) * | 1983-09-07 | 1983-10-12 | Erba Farmitalia | 16-fluoro-16 17-didehydro prostanoids |
| US5185374A (en) * | 1988-05-11 | 1993-02-09 | K.K. Ueno Seiyaku Oyo Kenkyujo | Use of 15-ketoprostaglandin E or F compounds for uterine contraction |
| GB0112699D0 (en) * | 2001-05-24 | 2001-07-18 | Resolution Chemicals Ltd | Process for the preparation of prostglandins and analogues thereof |
| CN101948484B (zh) * | 2010-09-19 | 2012-07-11 | 武汉武药科技有限公司 | 一种曲伏前列素中间体的制备方法 |
-
1974
- 1974-04-11 GB GB16242/74A patent/GB1484591A/en not_active Expired
-
1975
- 1975-04-08 US US05/566,146 patent/US3978229A/en not_active Expired - Lifetime
- 1975-04-09 FR FR7511037A patent/FR2267091B1/fr not_active Expired
- 1975-04-10 IE IE818/75A patent/IE40977B1/xx unknown
- 1975-04-10 NL NL7504303A patent/NL7504303A/xx not_active Application Discontinuation
- 1975-04-10 ZA ZA00752304A patent/ZA752304B/xx unknown
- 1975-04-10 AU AU80038/75A patent/AU497401B2/en not_active Expired
- 1975-04-10 LU LU72258A patent/LU72258A1/xx unknown
- 1975-04-10 CA CA224,288A patent/CA1049410A/fr not_active Expired
- 1975-04-10 DK DK154975AA patent/DK137977B/da not_active IP Right Cessation
- 1975-04-10 BE BE155295A patent/BE827804A/fr unknown
- 1975-04-10 SE SE7504150A patent/SE7504150L/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US3978229A (en) | 1976-08-31 |
| FR2267091B1 (fr) | 1981-03-27 |
| DK137977B (da) | 1978-06-19 |
| IE40977B1 (en) | 1979-09-26 |
| DK137977C (fr) | 1978-11-13 |
| LU72258A1 (fr) | 1976-03-17 |
| ZA752304B (en) | 1976-03-31 |
| AU8003875A (en) | 1976-10-14 |
| FR2267091A1 (fr) | 1975-11-07 |
| NL7504303A (nl) | 1975-10-14 |
| CA1049410A (fr) | 1979-02-27 |
| DK154975A (fr) | 1975-10-12 |
| GB1484591A (en) | 1977-09-01 |
| IE40977L (en) | 1975-10-11 |
| BE827804A (fr) | 1975-10-10 |
| AU497401B2 (en) | 1978-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1515414A (en) | 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins | |
| SE7504150L (sv) | Prostaglandin kompositioner | |
| ES428889A1 (es) | Procedimiento de preparacion de derivados de acido prosta- noico. | |
| GB1450960A (en) | Stabilization of prostaglandins | |
| ES436117A1 (es) | Procedimiento para la preparacion de nuevos compuestos ana- logos de acidos prostanoicos que no se presentan en la natu-raleza. | |
| GB1450691A (en) | Prostaglandin analogues | |
| GB1488006A (en) | Prostaglandin analogues | |
| SE7705947L (sv) | Prostaglandinprekursorer | |
| GB1299136A (en) | Improvements in or relating to prostaglandins and the preparation thereof | |
| GB1483240A (en) | Prostaglandin analogues | |
| GB1497218A (en) | Thiaprostaglandins | |
| ES439322A1 (es) | Procedimiento para la preparacion de nuevos derivados de a- cido prostanoico. | |
| GB1506816A (en) | Prostaglandins | |
| GB1458315A (en) | Prostanoic acid derivatives | |
| GB1449882A (en) | Prostaglandin analogues | |
| GB1486832A (en) | Prostanoic acid derivatives | |
| GB1461643A (en) | Cycloalkylidenol and cycloalkenol analogues of prostaglandins e and f | |
| GB1464205A (en) | Prostaglandins | |
| GB1419221A (en) | Calthrate prostaglandins and compositions containing same | |
| ES422831A1 (es) | Procedimiento para la obtencion de derivados de ciclopenta-no. | |
| ES432238A1 (es) | Procedimiento para la preparacion de nuevos compuestos ana- logos de acidos prostanoicos que no se presentan en la natu-raleza. | |
| GB1464206A (fr) | ||
| GB1530154A (en) | Prostaglandin analogues | |
| GB1492439A (en) | Prostaglandins | |
| GB1438093A (en) | Prostaglandins and the manufacture thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7504150-9 Effective date: 19770420 Format of ref document f/p: F |